David Soergel insider trades

Open-market stock purchases and sales by David Soergel, Chief Medical Officer at Madrigal Pharmaceuticals, Inc, from SEC Form 4 filings since Feb 20, 2014.

Recent trades

DateStockTradeValue
Jun 1, 2026MDGL Madrigal Pharmaceuticals, IncSold$517K
May 18, 2026MDGL Madrigal Pharmaceuticals, IncSold$435K
Mar 4, 2026MDGL Madrigal Pharmaceuticals, IncBought (not open market)—
Mar 4, 2026MDGL Madrigal Pharmaceuticals, IncBought (not open market)—

Companies traded

  • MDGL Madrigal Pharmaceuticals, Inc: 2 sales, last Jun 1, 2026
  • TRVN Trevena Inc: 3 buys, 1 sale, last Mar 2, 2017

Get free alerts when David Soergel files a new trade →